How We Cover CBD And Other Cannabinoids: Forbes Health Practices and Policies

Have a question we may not have answered?
Ask our editors here

Have a question for Alena Hall or our other editors?

Ask here for a chance to be featured in a story.

This form is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.

Send a note to Alena Hall and our other editors. We read every email.

By submitting this form, you agree to allow us to collect, store, and potentially publish your provided information, including name and question, in the article or any related content. You confirm that the submitted content is original, accurate, and non-infringing on any third-party rights. We may contact you via the email address provided for follow-up questions or to notify you if your question is selected for publication. See our Terms of Use and our Privacy Policy.
Thank you for submitting your question.

Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up questions.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

Cannabidiol (CBD) is one of the latest ingredients to take the health world by storm. Derived from both hemp and cannabis plants, CBD, as well as other cannabinoids, spark curiosity in some and skepticism in others. Meanwhile, a lack of federal regulations surrounding the substance in the U.S. makes it particularly challenging to parse fact from fiction when it comes to consumer health and safety.

We at Forbes Health take our role of providing you with accurate, research-supported, and expert-backed information very seriously—especially when it comes to murky topics like CBD and other hemp and cannabis cannabinoids.

The Legal Landscape of CBD

Hemp is defined as a cannabis plant that contains no more than 0.3% THC by dry weight. Meanwhile, marijuana is a cannabis plant that contains more than 0.3% THC by dry weight. Any cannabis plant containing more than 0.3% THC is considered non-hemp cannabis—or marijuana—under federal law.

The Farm Bill Act, among other changes, removed hemp’s classification as marijuana under the Controlled Substances Act, effectively making hemp-derived products legal. However, the 2018 Farm Bill explicitly preserved the U.S. Food and Drug Administration’s authority over hemp products. Therefore, hemp products must meet any applicable FDA requirements and standards just like any other FDA-regulated product under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

At a minimum, states have approved the use of FDA-approved products that contain less than 0.3% THC. Some states have a cap of 0.05% THC while others have legalized marijuana entirely. Some states expressly permit the use of CBD gummies that fall within these guidelines. This variance puts local regulations in misalignment with federal guidelines. As of right now, CBD is neither approved for inclusion in food nor as a dietary supplement.

Our Stance on CBD

It is our editorial policy to not make unsubstantiated or unscientific claims in our content or recommend products derived from marijuana. Similar to our other areas of health coverage, all health claims must be attributable to a scientific study in order to align with requirements of the Federal Trade Commission (FTC), and marijuana-derived products remain illegal in most states and have not been removed from the federal list of controlled substances.

Generally speaking, the use of hemp-derived CBD is legal under the Farm Bill Act. In our coverage of such products:

  • We will not recommend products that derive CBD from non-hemp sources (sources containing more than 0.3% THC by dry weight).
  • We will not make unsubstantiated claims that cannot be scientifically validated.
  • We will not recommend CBD products as dietary supplements or as part of a healthy diet or wellness regimen.

It is our goal and privilege to serve as your trusted source for safe and accurate CBD information. When reading any of our CBD content, know that it was carefully written, edited and fact-checked prior to publication. What’s more, we are paying constant attention to the legal landscape of CBD and cannabis to ensure our content accurately reflects any changes that should occur.

Next Up In CBD

Information provided on Forbes Health is for educational purposes only. Your health and wellness is unique to you, and the products and services we review may not be right for your circumstances. We do not offer individual medical advice, diagnosis or treatment plans. For personal advice, please consult with a medical professional.

Forbes Health adheres to strict editorial integrity standards. To the best of our knowledge, all content is accurate as of the date posted, though offers contained herein may no longer be available. The opinions expressed are the author’s alone and have not been provided, approved or otherwise endorsed by our advertisers.